Breyanzi car t cell lymphoma therapy
Ended Awarded
- Contract number
- 36C24924N0363
- Awardee
-
Bristol-Myers Squibb Company UEI UFGKB2B71N12
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $310,936
Award facts
- Contract value 100% obligated
- $310,935.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Irving, TX 75039, USA
Award details come from SAM.gov/FPDS.
About this award
Bristol-Myers Squibb Company was awarded a $310,935.67 delivery order for BREYANZI CAR T cell lymphoma therapy against the Pharmaceuticals and Drugs Federal Supply Schedule contract. The delivery order was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9, with work to be performed in Irving, Texas by April 1, 2024. Bristol-Myers Squibb will provide the chimeric antigen receptor (CAR) T cell immunotherapy BREYANZI under a firm fixed price arrangement. No set-aside designation was applied to this delivery order issued against the company's Pharmaceuticals and Drugs Federal Supply Schedule contract to support the Department of Veterans Affairs' mission of providing healthcare services to eligible military veterans.
Quick answers
Who was awarded contract 36C24924N0363?
36C24924N0363 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 9 (Veterans Health Administration) on March 8, 2024.
How much is contract 36C24924N0363 worth?
The government has obligated $310,936 on 36C24924N0363.
Is contract 36C24924N0363 an order under another contract?
Yes. 36C24924N0363 is a delivery order under 36F79718D0405, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24924N0363 competed?
The extent of competition for 36C24924N0363 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award